September 22, 2014
Lower open expected; RegMed’s sense of sensibilities
September 16, 2014
RegMed: A day of spilt milk
September 16, 2014
Lower open expected; RegMed remains under attack
September 9, 2014
Aastrom’s (ASTM) investors are on the edge
September 9, 2014
Lower open expected; RegMed’s ASTM’s investors are on the edge
September 8, 2014
Lower open expected; RegMed’s decliners are slowing
September 5, 2014
RegMed feels the pain
September 3, 2014
Higher open expected; RegMed is in uncharted territory
August 28, 2014
Advanced Cell Technology (ACTC-D) 1:100 reverse split of its common stock to enable up-listing – HOLD until it “seasons”
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.